Study tests if staying on GLP-1 drugs after bariatric surgery boosts weight loss

NCT ID NCT06132477

First seen Jan 26, 2026 · Last updated May 08, 2026 · Updated 13 times

Summary

This study looks at whether continuing GLP-1 medications (like Ozempic or Wegovy) after bariatric surgery helps people lose more weight and control blood sugar better than stopping them. About 150 adults with severe obesity, some with diabetes, will be randomly assigned to keep or stop their GLP-1 meds around the time of surgery. Researchers will track weight, blood sugar, hunger, and gut health for 6 months to see if staying on the meds provides extra benefits.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • University of Missouri Hospital

    RECRUITING

    Columbia, Missouri, 65201, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.